TREACE MEDICAL CONCEPTS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $212.7 | $209.4 | $187.1 | $141.8 | $94.4 |
| Operating income | -$54.2 | -$55.7 | -$51.4 | -$34.8 | -$16.5 |
| Net income | -$59.0 | -$55.7 | -$49.5 | -$42.8 | -$20.6 |
| Balance Sheet | |||||
| Total debt | $60.0 | $54.0 | $54.0 | $54.0 | $30.0 |
| Cash Flow Statement | |||||
| Free cash flow | -$29.5 | -$48.8 | -$46.0 | -$45.5 | -$19.9 |
Shares outstanding 65.0M · Free float 52.7%
Annual filing data through FY ended December 31, 2025; float as of September 11, 2026.